Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Doxorubicin Neoadjuvant Therapy in Large Breast Cancer
NCT00461344Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jul 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Sanofi. Started Jul 2004; status: terminated.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00461344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461344.